McKesson Corporation reported $411.0B of revenue over the trailing twelve months, +8.8% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $411.0B (to Q1 2027). Net income: $4.59B, trailing twelve months to Q1 2027. Free cash flow: $6.42B, trailing twelve months to Q1 2027. Operating margin: 1.6%, trailing twelve months to Q1 2027.

MCKMcKesson Corporation

Healthcare

$938.60+36% 1Y

$938.60

$695.0052 weeks$994.59

MCK as reported

McKesson Corporation reported $411.0B of revenue over the trailing twelve months, +8.8% on the year before. 11 reported series are charted on this page, each one as filed.

$411.0B

Revenue, trailing twelve months · to Q1 2027 · +8.8% against the twelve months before

Net income: $4.59B
Net income · +45% year on year · trailing twelve months to Q1 2027
Free cash flow: $6.42B
Free cash flow · +6.8% year on year · trailing twelve months to Q1 2027
Operating margin: 1.6%
Operating margin · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for MCK, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$411.0B	+8.8%	Q1 2027
Net income	$4.59B	+45%	Q1 2027
EPS	$37.31	+49%	Q1 2027
Gross margin	3.7%	n/a	Q1 2027
Operating margin	1.6%	n/a	Q1 2027
Net margin	1.1%	n/a	Q1 2027
ROE	−223%	n/a	Q1 2027
ROA	5.2%	n/a	Q1 2027
ROIC	818%	n/a	Q1 2027
Free cash flow	$6.42B	+6.8%	Q1 2027
P/E	25.2	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.